← FDA Drug Approvals (Drugs@FDA)

EPOPROSTENOL SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2008-04-23

Drug application

FDA Application #

ANDA078396

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPOPROSTENOL SODIUM

Generic name

Epoprostenol Sodium

Active ingredients

EPOPROSTENOL SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

MEITHEAL

First approval

2008-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown